JONBUR Research · Initiation
Samsung Life Insurance · 032830 · Insurance
Samsung Life Insurance: Shares Pull Back Sharply From Highs While Earnings Edge Higher and Valuation Data Is Mixed
Samsung Life's shares closed at ₩267,500 on 2026-10-12, down 13.0% over one month and 17.9% over three months, yet still up 67.2% over one year. Filed numbers show operating income and net income rising since 2023, while ROE is low at 3.2% and the P/E has moved above its 2025 year-end level.
Written Oct 13, 2026 · Data as of Oct 12, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
Thesis
The data supports a picture of steadily growing profit alongside a large price swing. Net income rose from ₩1.9T in 2023 to ₩2.3T in 2025, and ₩2.8T over the trailing period to H1 2026. The share price sits well below its 52-week high of ₩516,500 but far above the low of ₩144,000, so the past year has been very volatile.
The data does not explain the recent decline. Investor flows, foreign ownership and short balance are not available. The data also does not provide revenue, so margins cannot be measured. Valuation is mixed: price-to-book is 0.4, but P/E is 19.1, above the 13.7 at the end of 2025.
Business overview
Samsung Life Insurance is a KOSPI-listed insurer (code 032830) founded on 1957-04-04 and listed on 2010-05-12. It has 200,000,000 listed shares and a market capitalisation of ₩53.5T at the latest close. The CEO is listed as 홍원학. Enterprise value is ₩48.7T. Among the listed insurers in the data, Samsung Fire & Marine (₩28.6T) and DB Insurance (₩13.7T) are the next largest by market cap, both well below Samsung Life.
Financial analysis
These figures come from filed financial statements (DART). Revenue is not available in the data, so revenue growth and margins cannot be calculated.
Operating income was ₩2.4T in 2023, ₩2.5T in 2024 and ₩2.6T in 2025. Net income was ₩1.9T, ₩2.1T and ₩2.3T over the same years. For the trailing period to H1 2026, operating income was ₩2.9T and net income was ₩2.8T.
ROE was 4.5% in 2023, 5.8% in 2024 and 4.9% in 2025, and is 3.2% for the trailing period. Liabilities-to-equity is 213.2%. Cash is ₩4.8T and free cash flow is ₩1.4T. Borrowings are not available.
Valuation
The current P/E is 19.1 and P/B is 0.4. At the end of 2025 the P/E was 13.7 and the P/B 0.5, so earnings multiples are higher now while book value multiples are slightly lower. Earlier year-end multiples are not available. The dividend yield is 1.9%. P/S and EV/EBITDA are not available.
Among peers, only Samsung Fire & Marine has multiples in the data, with a P/E of 13.3 and a P/B of 0.8. Samsung Life is therefore at a lower P/B and a higher P/E than that peer. The other peers have no multiples, so a wider comparison is not possible.
Catalysts
- On 2026-10-08 the company filed a material matters report on a decision to issue debt securities recognized as capital, which bears on its capital position.
- Responses to rumour or news reports were filed on 2026-09-03 and 2026-10-02, though the data does not state their content.
- The half-year report for June 2026 was filed on 2026-08-14, after preliminary consolidated earnings on 2026-08-13.
- Several related-party transaction filings appeared in late August and September 2026, which investors may want to review.
- A news headline dated 2026-10-13 reports the launch of a revised whole life insurance product that waives premiums on cancer diagnosis.
Risks
- The share price fell 13.0% in one month and 17.9% in three months, showing high volatility.
- ROE of 3.2% is below the 2024 level of 5.8%, so returns on equity have weakened.
- Liabilities-to-equity of 213.2% shows meaningful balance sheet leverage, and the planned capital debt issuance adds to this.
- The P/E of 19.1 is above the 13.7 at the end of 2025, so earnings support the price less than before.
- Missing data on revenue, investor flows, foreign ownership and short interest limits how fully the recent move can be explained.
Closing view
The filed numbers show growing profit, a large cash balance and positive free cash flow, but returns on equity are low and have slipped. The shares trade at a low multiple of book value and a higher multiple of earnings than at the end of 2025, after a sharp three-month decline from a much higher 52-week peak. Gaps in the data, including revenue, flows and the content of the rumour responses, mean the reasons for the move cannot be confirmed from this information alone.
Model estimate of fair value
The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).
Report history
Source: KRX statistical information